Skip to content

What does a standard 5 panel drug test look for?

4 min read

The 5-panel drug test is the most common form of workplace and federally mandated drug screening in the United States, used widely by the Department of Transportation (DOT) and many private employers. So, what does a standard 5 panel drug test look for? It identifies the presence of metabolites from five key drug categories.

Quick Summary

A standard 5-panel test detects the metabolites of amphetamines, cocaine, marijuana (THC), opioids, and phencyclidine (PCP) in a sample, typically urine. The test is often employed for pre-employment, random, and post-accident screenings.

Key Points

  • Amphetamines: A standard 5-panel test detects metabolites of amphetamine, methamphetamine, MDMA (ecstasy), and MDA.

  • Cocaine: The test looks for benzoylecgonine, a metabolite of cocaine, to indicate use.

  • Marijuana (THC): The test identifies the presence of THC-COOH, a metabolite of THC, which has a variable detection window based on usage.

  • Opioids: The expanded opioid panel includes codeine, morphine, heroin, hydrocodone, hydromorphone, oxycodone, and oxymorphone.

  • Phencyclidine (PCP): The test screens specifically for PCP, a dissociative and hallucinogenic drug.

  • Sample Type: Urine is the most common sample, but hair, blood, and saliva can also be used, with varying detection times.

  • Confirmation Process: Positive screening results are confirmed with advanced lab testing (GC/MS) and reviewed by an MRO to account for valid medical explanations.

In This Article

The Standard 5 Drug Categories

A standard 5-panel drug test is designed to detect the presence of the five most commonly misused and potentially dangerous classes of drugs. While the '5-panel' refers to the number of drug categories, each panel can actually screen for multiple related substances and their metabolites. Urine is the most common sample type, but hair, blood, or saliva can also be used, with each offering a different detection window.

1. Amphetamines

This category includes powerful central nervous system stimulants. The test looks for the presence of amphetamine and methamphetamine, as well as related drugs.

  • Substances detected: Amphetamine, Methamphetamine (crystal meth), MDMA (ecstasy), and MDA.
  • Purpose: Amphetamines are tested due to their potential for abuse and significant impact on cognitive and physical abilities, posing a safety risk in the workplace. The test can also detect prescription stimulants like Adderall or Ritalin, so a medical explanation reviewed by a Medical Review Officer (MRO) is crucial in case of a positive result.

2. Cocaine

Derived from the coca plant, cocaine is a highly addictive stimulant. The 5-panel test does not search for the parent drug itself, but rather its primary metabolite.

  • Substance detected: Benzoylecgonine, a metabolite of cocaine.
  • Purpose: The test identifies recent use of cocaine or crack cocaine by detecting its metabolites in the body. The detection window is relatively short in urine, typically lasting 2 to 4 days.

3. Marijuana (THC)

As cannabis laws evolve, testing for marijuana remains standard in federally regulated industries like transportation. The test targets the psychoactive component, THC.

  • Substance detected: THC-COOH, the primary inactive metabolite of THC.
  • Purpose: The presence of this metabolite indicates cannabis consumption. The detection time for THC-COOH in urine can vary significantly, from a few days for occasional users to a month or longer for chronic users, depending on factors like frequency of use, metabolism, and dosage.

4. Opioids

Effective since 2018 for federally regulated testing, the opioid panel is an expansion of the former opiates panel. It tests for a broader range of both naturally derived and semi-synthetic opioids.

  • Substances detected: Codeine, Morphine, Heroin (detected via its metabolite, 6-AM), Hydrocodone (e.g., Vicodin), Hydromorphone, Oxycodone (e.g., OxyContin), and Oxymorphone.
  • Purpose: This expanded panel is crucial for monitoring the use of both illicit opioids like heroin and commonly abused prescription painkillers. A positive result for a prescription opioid is reviewed by an MRO to confirm it is not the result of a valid prescription.

5. Phencyclidine (PCP)

PCP, or "angel dust," is a hallucinogenic and dissociative drug that can produce powerful mind-altering effects.

  • Substance detected: Phencyclidine (PCP).
  • Purpose: PCP is included in the standard panel due to its potential for dangerous and unpredictable behavior, making it a significant safety concern.

Comparison of Detection Methods

The choice of sample collection method for a 5-panel drug test depends on various factors, including the required detection window and setting.

Feature Urine Test Hair Follicle Test Oral Fluid (Saliva) Test
Detection Window Days to a few weeks (variable by drug) Up to 90 days Up to 48 hours
Best For Common for pre-employment, random, and post-accident testing due to affordability and accuracy for recent use. Detecting long-term drug use. Detecting very recent drug use, for post-incident testing.
Collection Method Sample is collected in a private restroom under controlled conditions. A small hair sample (usually 1.5 inches) is taken from the head. A swab is used to collect saliva from inside the mouth.
Specimen Validity Often includes validity tests to check for adulteration, substitution, or dilution. Highly resistant to tampering due to collection process. Less invasive, but offers a very short detection window.

Understanding Test Results

Following an initial screening test, positive results are sent for a confirmatory test, such as Gas Chromatography/Mass Spectrometry (GC/MS) or Liquid Chromatography/Mass Spectrometry (LC/MS), to ensure accuracy. Confirmed positive results are then reviewed by a Medical Review Officer (MRO), a licensed physician. The MRO contacts the donor to discuss any valid medical explanations for the result, such as a legally obtained prescription, before certifying a positive result to the employer. This process helps prevent false positives from leading to unfair employment decisions. Regulations and requirements for drug testing are often guided by agencies like the Substance Abuse and Mental Health Services Administration (SAMHSA).

Conclusion

In summary, a standard 5-panel drug test provides a reliable snapshot of an individual's recent exposure to the five most commonly abused drug categories: amphetamines, cocaine, marijuana, opioids, and PCP. This screening tool is a key part of maintaining safety in many workplaces and regulated industries. For individuals subject to such testing, understanding what it looks for is the first step toward navigating the process successfully. While advancements in technology and changing regulations, like the expansion of the opioid panel, continue to evolve drug testing, the fundamental list of five drug categories remains the industry standard for many organizations.

For further information on federal drug testing guidelines, you can visit the SAMHSA website.

Frequently Asked Questions

No, a standard 5-panel drug test does not detect alcohol. Some tests can include alcohol testing as an add-on, but it is not part of the basic 5-panel screening.

Yes, it is possible. Certain over-the-counter medications, like Sudafed, can sometimes trigger a false positive on an initial screening for amphetamines. For this reason, positive tests are sent for more specific confirmation, and a Medical Review Officer will contact you to discuss any medications you are taking.

The detection window varies by substance. For urine, it can range from a few days for cocaine and opioids to up to a month or more for chronic marijuana use. Hair tests, by contrast, can detect drug use for up to 90 days.

The DOT mandates 5-panel urine drug tests for employees in safety-sensitive positions, such as truck drivers and pilots. They use these tests for pre-employment, random, and post-accident testing to ensure a drug-free and safe workplace.

The testing panel was renamed from 'opiates' to 'opioids' in 2018 to reflect an expanded scope. While opiates referred to natural drugs like morphine and codeine, the expanded opioid panel now also includes semi-synthetic opioids like hydrocodone and oxycodone.

An inconclusive result can occur for several reasons, including a testing error, or a suspected diluted or tampered sample. In this situation, the Medical Review Officer (MRO) may require a retest.

While the 5-panel test is a common standard, especially in federally regulated sectors, specific requirements and local laws can vary. Employers may also add more substances for testing, known as a wider panel test (e.g., 10-panel).

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.